Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mL

[논문]이한길, Sang Hoon Ahn, Sungin Jang, Beom Kyung Kim, Cost‑effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL, HEPATOLOGY INTERNATIONAL, Vol.16, No.2, pp.294- pp.305 (03월, 2022)

논문 링크: https://pubmed.ncbi.nlm.nih.gov/35322374/

DOI: 10.1007/s12072-022-10310-1